Clinical Trial Update: Pharmacokinetic Evaluation and Tolerability of Dry Powder Tobramycin by a Novel Device in Patients With Non Cystic Fibrosis Bronchiectasis [Phase 1, Phase 2]

View source ↗

Summary

Completed Phase 1/2 trial evaluating the pharmacokinetics and tolerability of a dry powder tobramycin inhalation device in patients with bronchiectasis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchiectasis

Drugs mentioned

• Dry powder tobramycin (tobramycin)

Snippet

Sponsor: University Medical Center Groningen | Conditions: Bronchiectasis | Phase 1, Phase 2 | Status: COMPLETED